Aadi Bioscience Stock Retained Earnings
| AADIDelisted Stock | USD 2.05 0.05 2.38% |
Aadi Bioscience fundamentals help investors to digest information that contributes to Aadi Bioscience's financial success or failures. It also enables traders to predict the movement of Aadi Stock. The fundamental analysis module provides a way to measure Aadi Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aadi Bioscience stock.
Aadi |
Aadi Bioscience Company Retained Earnings Analysis
Aadi Bioscience's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Aadi Bioscience Retained Earnings | (268.96 M) |
Most of Aadi Bioscience's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aadi Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, Aadi Bioscience has a Retained Earnings of (268.96 Million). This is 128.88% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The retained earnings for all United States stocks is 102.88% higher than that of the company.
Aadi Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aadi Bioscience's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aadi Bioscience could also be used in its relative valuation, which is a method of valuing Aadi Bioscience by comparing valuation metrics of similar companies.Aadi Bioscience is currently under evaluation in retained earnings category among its peers.
Aadi Fundamentals
| Return On Equity | -0.66 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (2.46) % | |||
| Operating Margin | (1.49) % | |||
| Current Valuation | 35.53 M | |||
| Shares Outstanding | 46.29 M | |||
| Shares Owned By Insiders | 6.09 % | |||
| Shares Owned By Institutions | 50.02 % | |||
| Number Of Shares Shorted | 764.36 K | |||
| Price To Book | 1.41 X | |||
| Price To Sales | 3.88 X | |||
| Revenue | 24.35 M | |||
| Gross Profit | (27.54 M) | |||
| EBITDA | (65.36 M) | |||
| Net Income | (65.77 M) | |||
| Cash And Equivalents | 118.74 M | |||
| Cash Per Share | 5.65 X | |||
| Total Debt | 1.27 M | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 9.87 X | |||
| Book Value Per Share | 2.80 X | |||
| Cash Flow From Operations | (59.66 M) | |||
| Short Ratio | 8.87 X | |||
| Earnings Per Share | (2.28) X | |||
| Target Price | 3.0 | |||
| Number Of Employees | 53 | |||
| Beta | 0.34 | |||
| Market Capitalization | 97.21 M | |||
| Total Asset | 132.42 M | |||
| Retained Earnings | (268.96 M) | |||
| Working Capital | 98.19 M | |||
| Net Asset | 132.42 M |
About Aadi Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aadi Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aadi Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aadi Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Aadi Stock
If you are still planning to invest in Aadi Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aadi Bioscience's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |